Design of a Targeted Covalent Probe to Interrogate the DNA Polymerase Activity of Polθ

Human DNA polymerase θ (Polθ) is essential for microhomology-mediated end-joining (MMEJ) and represents a therapeutic vulnerability in homologous recombination (HR)-deficient cancers. Although reversible inhibitors of Polθ have advanced into clinical development, covalent chemical probes remain unexplored. Analysis of a previously described structure of the reversible inhibitor <b>compound 37</b> bound to Polθ identified Cys2411 as an accessible residue 7.4 Å adjacent to the inhibitor binding site. Guided by X-ray crystallographic studies, we designed <b>compound 29</b> to reduce the separating distance between inhibitor and Cys2411 to 4.7 Å and then synthesized <b>RP-4029</b> by incorporating a vinyl sulfone electrophile. Functional studies revealed efficient covalent linkage to Cys2411 (<i>K</i> <sub>inact</sub> = 11.6 s<sup>-1</sup>), while a high-resolution (2.0 Å) cocrystal structure validated the design strategy. These findings establish Cys2411 as a privileged site for covalent inhibitor development and provide a highly potent, selective chemical probe useful for investigating Polθ biology.

Authors

Institutions

Publication Details

Journal
ACS Medicinal Chemistry Letters
Published
2026-01-07
DOI
https://doi.org/10.1021/acsmedchemlett.5c00643
Primary Topic
DNA Repair Mechanisms
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Design of a Targeted Covalent Probe to Interrogate the DNA Polymerase Activity of Polθ

Stephen Orlicky, P. Mäder, Claude Godbout, Michal Zimmermann et al.
ACS Medicinal Chemistry Letters
DNA Repair Mechanisms
article

Design of a Targeted Covalent Probe to Interrogate the DNA Polymerase Activity of Polθ

Stephen Orlicky, P. Mäder, Claude Godbout, Michal Zimmermann, Yaël Mamane, Martine Hamel, Michael J. Zinda, Alexander L. Perryman, Agnel J. Sfeir, Igor Kurinov, Cassandra Wong, Daniel Durocher, Michel Gallant, Jean-Pierre Falgueyret, Stephen J. Morris, Monica Bubenik, Frank Sicheri, Anne Claude Gingras, W. Cameron Black
article en

Abstract

Human DNA polymerase θ (Polθ) is essential for microhomology-mediated end-joining (MMEJ) and represents a therapeutic vulnerability in homologous recombination (HR)-deficient cancers. Although reversible inhibitors of Polθ have advanced into clinical development, covalent chemical probes remain unexplored. Analysis of a previously described structure of the reversible inhibitor <b>compound 37</b> bound to Polθ identified Cys2411 as an accessible residue 7.4 Å adjacent to the inhibitor binding site. Guided by X-ray crystallographic studies, we designed <b>compound 29</b> to reduce the separating distance between inhibitor and Cys2411 to 4.7 Å and then synthesized <b>RP-4029</b> by incorporating a vinyl sulfone electrophile. Functional studies revealed efficient covalent linkage to Cys2411 (<i>K</i> <sub>inact</sub> = 11.6 s<sup>-1</sup>), while a high-resolution (2.0 Å) cocrystal structure validated the design strategy. These findings establish Cys2411 as a privileged site for covalent inhibitor development and provide a highly potent, selective chemical probe useful for investigating Polθ biology.

ACS Medicinal Chemistry LettersVol. 17(2)
University of Toronto (CA), Cornell University (US), Lunenfeld-Tanenbaum Research Institute (CA), Kettering University (US), Io Therapeutics (United States) (US)
Openalex Percentile: Top 94%
DNA Repair Mechanisms
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.